Vetoquinol (FRA:8JM) Total Payout Ratio: 0.41 (As of Aug. 24, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:8JM Vetoquinol SA FRA:8JM
87 GF Score
Price €69.70
GF Value €84.66
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is Vetoquinol Total Payout Ratio?

Vetoquinol FRA:8JM -1.41% 87 Total Payout Ratio is 0.41 as of Aug. 24, 2026. GuruFocus rates FRA:8JM with a GF Score™ of 87/100 and a GF Value™ of €84.66 (Modestly Undervalued). The stock has 1 warning sign investors should review.

Total Payout Ratio is the percent a company has paid to its shareholders through net repurchase of shares and dividends based on its Net Income.

Vetoquinol's current Total Payout Ratio is 0.41.

Vetoquinol Total Payout Ratio Related Terms

Vetoquinol Total Payout Ratio Historical Data

* Premium members only.

The historical data trend for Vetoquinol's Total Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vetoquinol Total Payout Ratio Chart

Vetoquinol Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Payout Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.09 0.20 0.17 0.22 0.41

Vetoquinol Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Total Payout Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.42 0.00 0.74 0.16

FRA:8JM vs ZTS, UTHR, VTRS: Total Payout Ratio Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Vetoquinol's Total Payout Ratio, along with its competitors' market caps and Total Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Vetoquinol Total Payout Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Vetoquinol's Total Payout Ratio distribution charts can be found below:

* The bar in red indicates where Vetoquinol's Total Payout Ratio falls into.


FRA:8JM
87GF Score
Vetoquinol SA FRA:8JM
Total Payout Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Vetoquinol Total Payout Ratio Calculation

Total Payout Ratio is a measurement showing the proportion of earnings a company pays shareholders in the form of dividends and net stock repurchases.

Vetoquinol's Total Payout Ratio for the fiscal year that ended in Dec. 2025 is calculated as

Total Payout Ratio=- (Repurchase of Stock + Issuance of Stock + Cash Flow for Dividends) / Net Income
=- (-13.043 + 0 + -10.402) / 57.337
=0.41

Vetoquinol's Total Payout Ratio for the quarter that ended in Dec. 2025 is calculated as

Total Payout Ratio=- (Repurchase of Stock + Issuance of Stock + Cash Flow for Dividends) / Net Income
=- (-5.018 + 0 + 0) / 32.268
=0.16

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Payout Ratio →
What does a Total Payout Ratio of 0.41 mean?
Vetoquinol (FRA:8JM) has a Total Payout Ratio of 0.41 as of Aug. 24, 2026. Total Payout Ratio is the percent a company has paid to its shareholders through net repurchase of shares and dividends based on its Net Income. View historical data on Vetoquinol and its competitors.
Is Vetoquinol's Total Payout Ratio too high?
Vetoquinol's current Total Payout Ratio is 0.41. Overall, Vetoquinol has a GF Score™ of 87/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Vetoquinol's Total Payout Ratio compare to ZTS and UTHR?
Vetoquinol's Total Payout Ratio of 0.41 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Payout Ratio for a Drug Manufacturers company?
A good Total Payout Ratio depends on the Drug Manufacturers industry context. However, Total Payout Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Payout Ratio mean?
A high Total Payout Ratio can signal that a stock is expensive relative to its fundamentals. Total Payout Ratio is the percent a company has paid to its shareholders through net repurchase of shares and dividends based on its Net Income. View historical data on Vetoquinol and its competitors. Vetoquinol's current Total Payout Ratio is 0.41. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vetoquinol stock overvalued right now?
Based on GuruFocus' analysis, Vetoquinol (FRA:8JM) is currently considered Modestly Undervalued. The stock's GF Value™ is €84.66, compared to a current price of €69.70 — trading 17.7% below its estimated fair value. The current Total Payout Ratio is 0.41. Vetoquinol's overall GF Score™ is 87/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Payout Ratio calculated?
Total Payout Ratio is calculated from a company's financial statements. For Vetoquinol (FRA:8JM), the current Total Payout Ratio is 0.41 as of Aug. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Vetoquinol (FRA:8JM) Overvalued in 2026?

Based on GuruFocus' analysis, Vetoquinol stock appears to be undervalued. The current stock price of €69.70 is trading 17.7% below its estimated GF Value™ of €84.66. GuruFocus considers Vetoquinol to be Modestly Undervalued.

Key valuation signals for FRA:8JM:

  • Total Payout Ratio: 0.41
  • GF Value™: €84.66 vs. price of €69.70 (17.7% below fair value)
  • GF Score™: 87/100 with 1 warning sign

No single metric tells the full story. See the FRA:8JM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Vetoquinol Business Description

Other Exchanges 0O1O:UKVETO:France
Address Magny-Vernois, BP 189, Lure cedex, FRA, 70204
Vetoquinol SA operates is a France-based firm serving in the healthcare market. Its focus lies on developing and marketing veterinary drugs mainly in the European region and to a certain extent in America and Asia. Its portfolio of drugs entails anti-infectives, anti- pain inflammatory drugs, cardiovascular and nephrology treatment intended mainly for pets and livestock.
87GF Score

Get the complete analysis for FRA:8JM

Total Payout Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€69.70
Price
€84.66
GF Value